A drug for the prevention of oxidative stress in retinal ganglion cells and wet maculopathy
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHENGDU GENREZE GENE TECH CO LTD
- Publication Date
- 2021-11-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of retinal nerve medicine. Background technique
[0002] Oxidative stress (OS) refers to a state of imbalance between oxidation and anti-oxidation in the body, which tends to oxidize, leading to inflammatory infiltration of neutrophils, increased secretion of proteases, and production of a large number of oxidized intermediates. Oxidative stress is a negative effect of free radicals in the body and is believed to be an important factor in aging and disease.
[0003] Retinal ganglion cells are cells located in the innermost layer of the retina, whose main function is to receive electrical impulses transmitted from cones and rods to bipolar cells, and to transmit electrical impulses to the optic nerve to produce vision. Oxidative stress in retinal ganglion cells is involved in the pathological process of many diseases, including glaucoma, diabetes, age-related macular degeneration, optic nerve damage, etc. When retina...